STOK - Stoke Therapeutics GAAP EPS of -$0.57 revenue of $4.2M
2024-05-06 07:52:16 ET
More on Stoke Therapeutics
- Stoke Therapeutics: Positive Dravet Data Sends Shares Soaring, One For The Watchlist
- Stoke Therapeutics prices upsized equity offering of $125M
- Stoke Therapeutics announces proposed public offering worth $75M
- Seeking Alpha’s Quant Rating on Stoke Therapeutics
- Historical earnings data for Stoke Therapeutics